Amdocs Ltd DOX.OQ DOX.O is expected to show a fall in quarterly revenue when it reports results on February 4 for the period ending December 31 2024
The Saint Louis Michigan-based company is expected to report a 10.5% decrease in revenue to $1.115 billion from $1.25 billion a year ago, according to the mean estimate from 5 analysts, based on LSEG data.The company's guidance on November 12 2024, for the period ended December 31, was for revenue between $1.10 billion and $1.14 billion.
LSEG's mean analyst estimate for Amdocs Ltd is for earnings of $1.64 per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Amdocs Ltd is $100.09, above its last closing price of $87.46.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2024 | 1.70 | 1.70 | 1.70 | Met | 0.1 |
Jun. 30 2024 | 1.60 | 1.60 | 1.62 | Beat | 1 |
Mar. 31 2024 | 1.56 | 1.56 | 1.56 | Met | 0 |
Dec. 31 2023 | 1.56 | 1.56 | 1.56 | Met | -0.2 |
Sep. 30 2023 | 1.42 | 1.42 | 1.42 | Met | 0.2 |
Jun. 30 2023 | 1.48 | 1.48 | 1.57 | Beat | 6.1 |
Mar. 31 2023 | 1.47 | 1.47 | 1.47 | Met | 0.1 |
Dec. 31 2022 | 1.32 | 1.32 | 1.45 | Beat | 9.8 |
This summary was machine generated January 31 at 21:43 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。